TCOF1 in Extracellular Vesicles predicts survival in HCC patients treated with High-Dose Conformal Radiotherapy

Key Points

• The aim is to evaluate the prognostic significance of TCOF1 in extracellular vesicles for HCC patients undergoing high-dose conformal radiotherapy.
• Analysis of extracellular vesicles to measure TCOF1 levels
• Assessment of patient survival outcomes post-treatment
• Correlation of TCOF1 levels with treatment response
• Higher levels of TCOF1 in extracellular vesicles are associated with improved survival rates
• Patients with low TCOF1 levels show reduced survival after treatment
• TCOF1 serves as a potential biomarker for patient outcomes in HCC